Tonghua Dongbao Pharmaceutical Co., Ltd. is principally engaged in the manufacture and distribution of pharmaceuticals and construction materials. The Company's major products are gene-recombinant insulin lyophilized powders and injections, capsules, tablets, infusion products, plastic-steel windows and profiles, among others.

Tonghua Dongbao Pharmaceutical Co., Ltd. is a China-based company engaged in manufacture and sale of pharmaceuticals and construction materials. The Company also involves in research and development of bio-engineering technology and genetic engineering drugs. Its principal products are gene-recombinant insulin lyophilized powders and injections, capsules, tablets, infusion products, plastic-steel windows and profiles, among others. The Company distributes its products in domestic and overseas markets. As of December 31, 2008, the Company had four subsidiaries and affiliates, which involved in manufacture and sale of pharmaceuticals and construction materials.